Section 63, Clinical Establishments (Registration and Regulation) Act, 2010 [S25-MBP]
As at 6 September 2026. In force from 8 October 2010.
63. Appeal.—(1) Any person aggrieved by an order of the Licensing Authority under this Act may, within one hundred and twenty days from the date on which the order is communicated to him, prefer an appeal to the Drugs Controller in such form and accompanied by such fee as may be prescribed. (2) The appellate authority may, after giving the appellant an opportunity of being heard, confirm, modify or set aside the order appealed against. (3) No appeal shall lie under this section against an order made with the consent of the parties.
Defined terms in this text (2)
drug: Section 2, Clinical Establishments (Registration and Regulation) Act, 2010 [S25JE4] (In this Act, unless the context otherwise requires,—): "drug" includes all medicines for internal or external use of human beings or animals and all substances intended to be used for or in the diagnosis, treatment, mitigation or prevention of any disease or disorder in human beings or animals
drug: 19 more definitions.
Licensing Authority: Section 2, Clinical Establishments (Registration and Regulation) Act, 2010 [S25JE4] (In this Act, unless the context otherwise requires,—): "Licensing Authority" means the authority appointed under section 4 to grant licences under this Act
Licensing Authority: 21 more definitions.
Made under this section, or naming it (0)
none
Cited by (3)
Section 66, Clinical Establishments (Registration and Regulation) Act, 2010 [S25-MEW], 8 October 2010, Band A. "section 63".
Section 2, Clinical Establishments (Registration and Regulation) Act (Amendment) Act, 2020 [S2A-5SE], 3 December 2020, Band A. "section 63 of the Clinical Establishments (Registration and Regulation) Act, 2010 (23 of 2010)".
Rule 9, Clinical Establishments (Registration and Regulation) Act Rules, 2012 [S25-YFK], 13 January 2012, Band A. "section 63 of the Act".
Not held (0)
none
Duties published under this section (0)
none